Mylan announced the launch of Prednisolone Sodium Phosphate Orally Disintegrating Tablets, the generic of Shionogi’s Orapred ODT.

Orapred ODT acts as an anti-inflammatory or immunosuppressive agent for some conditions, and is also indicated for various endocrine conditions, and for palliation of certain neoplastic conditions. Prednisolone is a synthetic adrenocortical steroid with predominantly glucocorticoid properties. Some pharmacological effects include: promotion of gluconeogenesis, increased deposition of glycogen in the liver, inhibition of utilization of glucose, anti-insulin activity, increased catabolism of protein, increased lipolysis, and others.

RELATED: For Some Children, Prednisolone May Protect from Recurrent Wheezing

Prednisolone Sodium Phosphate Orally Disintegrating Tablets is available in 10mg, 15mg, and 30mg, strengths.

For more information call (800) RX-MYLAN or visit